良性前列腺增生有什麼治療方法？ - 馬偉傑泌尿外科專科醫生＠FindDoc.com
FindDoc Facebook : https://www.facebook.com/FindDoc
FindDoc WeChat : 快徳健康香港 FindDoc
FindDoc Instagram：@finddochk
立即進行1分鐘小測試，了解自己出現常見泌尿疾病的風險：https://bit.ly/39diYgw
（一）甚麼是良性前列腺增生？ 00:06
（二）良性前列腺增生有甚麼治療方法？ 00:48
（三）荷爾蒙及非荷爾蒙治療藥理上有甚麼分別？ 01:33
（四）手術、荷爾蒙及非荷爾蒙治療的風險／副作用分別是甚麼？ 02:27
（本短片作健康教育之用，並不可取代任何醫療診斷或治療。治療成效因人而異，如有疑問，請向專業醫療人士諮詢。)
參考資料：
1. 衞生署 衞生防護中心 - 男性常見疾病 - 良性前列腺肥大症. (n.d.). Retrieved February 19, 2021, from https://www.chp.gov.hk/tc/static/80028.html
2. 衞生署 藥物辦公室 - 治療良性前列腺增生口服藥. (2016). Retrieved February 19, 2021, from https://www.drugoffice.gov.hk/eps/do/tc/consumer/news_informations/dm_34.html
3. Nicholson, T. M., & Ricke, W. A. (2011). Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation; research in biological diversity, 82(4-5), 184–199. https://doi.org/10.1016/j.diff.2011.04.006
4. Osman, N. I., Mangera, A., & Chapple, C. R. (2014). Non-Hormonal treatment of BPH/BOO. Indian journal of urology : IJU : journal of the Urological Society of India, 30(2), 194–201. https://doi.org/10.4103/0970-1591.126906
5. Hong Kong Urological Association. (2014). 良性前列腺增生. https://www.hkua.org/%E8%89%AF%E6%80%A7%E5%89%8D%E5%88%97%E8%85%BA%E5%A2%9E%E7%94%9F/.
6. Gravas , S., Cornu, J. N., Gratzke, C., W, T. R., Mamoulakis, C., & Rieken, M. (2021.). EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Management-of-Non-Neurogenic-Male-LUTS-2021.pdf.
7. Barkin , J. (2011). Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management. The Canadian Journal of Urology , 18. https://canjurol.com/pdfs/supplemets/update2011/BPH-Dr-Barkin.pdf.
8. Traish, A., Haider, K. S., Doros, G., & Haider, A. (2017). Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction. Hormone Molecular Biology and Clinical Investigation, 30(3). https://doi.org/10.1515/hmbci-2017-0015
9. Wei, L., Lai, E. C.-C., Kao-Yang, Y.-H., Walker, B. R., MacDonald, T. M., & Andrew, R. (2019). Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study. BMJ, l1204. https://doi.org/10.1136/bmj.l1204
10. Hofner , K., Claes, H., De Reijke, T. M., Folkestad, B., & Speakman, M. J. (1999). Tamsulosin 0.4 mg Once Daily: Effect on Sexual Function in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction. European Urology, 36(4), 335–341. https://doi.org/10.1159/000019996
11. Chapple, C. R. (2005). A Comparison of Varying α-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. Reviews in Urology , 7(4), 22–30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477612/.
12. Lepor, H. (2016). Alpha-blockers for the treatment of benign prostatic hyperplasia. Urologic Clinics, 43(3), 311-323.
13. Narayan, P., & Tewari, A. (1998). Overview of α-blocker therapy for benign prostatic hyperplasia. Urology, 51(4), 38-45.
14. Horninger, W., Unterlechner, H., Strasser, H., & Bartsch, G. (1996). Transurethral prostatectomy: Mortality and morbidity. The Prostate, 28(3), 195–200.
15. Mebust, W. K., Holtgrewe, H. L., Cockett, A. T. K., Peters, P. C., & Writing Committee. (2002). Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. The Journal of urology, 167(2 Part 2), 999-1003.
資料來源：https://www.FindDoc.com
查詢醫生資訊：https://www.finddoc.com/
FindDoc Facebook : https://www.facebook.com/FindDoc
FindDoc WeChat : 快徳健康香港 FindDoc
FindDoc Instagram：@finddochk
立即進行1分鐘小測試，了解自己出現常見泌尿疾病的風險：https://bit.ly/39diYgw
（一）甚麼是良性前列腺增生？ 00:06
（二）良性前列腺增生有甚麼治療方法？ 00:48
（三）荷爾蒙及非荷爾蒙治療藥理上有甚麼分別？ 01:33
（四）手術、荷爾蒙及非荷爾蒙治療的風險／副作用分別是甚麼？ 02:27
（本短片作健康教育之用，並不可取代任何醫療診斷或治療。治療成效因人而異，如有疑問，請向專業醫療人士諮詢。)
參考資料：
1. 衞生署 衞生防護中心 - 男性常見疾病 - 良性前列腺肥大症. (n.d.). Retrieved February 19, 2021, from https://www.chp.gov.hk/tc/static/80028.html
2. 衞生署 藥物辦公室 - 治療良性前列腺增生口服藥. (2016). Retrieved February 19, 2021, from https://www.drugoffice.gov.hk/eps/do/tc/consumer/news_informations/dm_34.html
3. Nicholson, T. M., & Ricke, W. A. (2011). Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation; research in biological diversity, 82(4-5), 184–199. https://doi.org/10.1016/j.diff.2011.04.006
4. Osman, N. I., Mangera, A., & Chapple, C. R. (2014). Non-Hormonal treatment of BPH/BOO. Indian journal of urology : IJU : journal of the Urological Society of India, 30(2), 194–201. https://doi.org/10.4103/0970-1591.126906
5. Hong Kong Urological Association. (2014). 良性前列腺增生. https://www.hkua.org/%E8%89%AF%E6%80%A7%E5%89%8D%E5%88%97%E8%85%BA%E5%A2%9E%E7%94%9F/.
6. Gravas , S., Cornu, J. N., Gratzke, C., W, T. R., Mamoulakis, C., & Rieken, M. (2021.). EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Management-of-Non-Neurogenic-Male-LUTS-2021.pdf.
7. Barkin , J. (2011). Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management. The Canadian Journal of Urology , 18. https://canjurol.com/pdfs/supplemets/update2011/BPH-Dr-Barkin.pdf.
8. Traish, A., Haider, K. S., Doros, G., & Haider, A. (2017). Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction. Hormone Molecular Biology and Clinical Investigation, 30(3). https://doi.org/10.1515/hmbci-2017-0015
9. Wei, L., Lai, E. C.-C., Kao-Yang, Y.-H., Walker, B. R., MacDonald, T. M., & Andrew, R. (2019). Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study. BMJ, l1204. https://doi.org/10.1136/bmj.l1204
10. Hofner , K., Claes, H., De Reijke, T. M., Folkestad, B., & Speakman, M. J. (1999). Tamsulosin 0.4 mg Once Daily: Effect on Sexual Function in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction. European Urology, 36(4), 335–341. https://doi.org/10.1159/000019996
11. Chapple, C. R. (2005). A Comparison of Varying α-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. Reviews in Urology , 7(4), 22–30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1477612/.
12. Lepor, H. (2016). Alpha-blockers for the treatment of benign prostatic hyperplasia. Urologic Clinics, 43(3), 311-323.
13. Narayan, P., & Tewari, A. (1998). Overview of α-blocker therapy for benign prostatic hyperplasia. Urology, 51(4), 38-45.
14. Horninger, W., Unterlechner, H., Strasser, H., & Bartsch, G. (1996). Transurethral prostatectomy: Mortality and morbidity. The Prostate, 28(3), 195–200.
15. Mebust, W. K., Holtgrewe, H. L., Cockett, A. T. K., Peters, P. C., & Writing Committee. (2002). Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. The Journal of urology, 167(2 Part 2), 999-1003.
資料來源：https://www.FindDoc.com
查詢醫生資訊：https://www.finddoc.com/
